Diversify your portfolio in 2025 with low-correlation risk baskets and unique models, including highlighted trades and market ...

Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the ...

Delcath Systems announced the exercise of 1.7 million Series E and E1 warrants, resulting in $16.3 million in funding. This financial boost positions Delcath to strengthen its commercialization ...

纽约州皇后区 - 专注于介入性肿瘤治疗的Delcath Systems, Inc. (NASDAQ:DCTH)宣布成功行使E系列和E1系列权证，为公司筹集了1630万美元资金。这些权证是2019年7月和8月私募配售的一部分，将于2024年12月24日到期。根据 InvestingPro 数据，该公司在过去12个月内收入增长了946%，目前市值为3.82亿美元。

As the United States stock market navigates a volatile period marked by fluctuations in major indices and a notable slump in big-tech stocks, investors are increasingly focused on identifying ...

Check the time stamp on this data. Updated AI-Generated Signals for Delcath Systems Inc. (DCTH) available here: DCTH. Type a few symbols and Take a Trial. The signals for these will appear immediately ...

We feel now is a pretty good time to analyse Delcath Systems, Inc.'s ( NASDAQ:DCTH ) business as it appears the ...

Delcath Systems (DCTH) (ISIN: US24661P8077)股票专题，提供今日Delcath Systems(DCTH) (ISIN: US24661P8077)股票最新股价查询，实时市场行情，走势图表，及Delcath Systems(DCTH) (ISIN: US24661P8077)股票的专业技术分析，投资者论坛，历史交易数据，最新消息和未来价格预测。

Shares of MicroStrategy Incorporated MSTR fell sharply in today's pre-market trading following the company's announcement to issue more shares to finance additional Bitcoin BTC/USD acquisitions. This ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...